Alzheimer's disease
Blood-based tests show potential for early Alzheimer’s detection
Blood-based tests show potential for early Alzheimer’s detection
More than 150 in vitro diagnostic tests are currently in development.
Neuroglee secures $10m funding to advance home-based Alzheimer's treatment
Openspace Ventures led the Series A round.
Most Read
1. Agentic AI cuts drug development timelines: report 2. Biopharma firms face $275b patent cliff as returns stall 3. iX Biopharma secures $52.8m US contract for pain reliever trials 4. DBS’ $72m loan to PLife REIT to finance elder care in Japan 5. Aging population drives demand for durable medical equipment marketResource Center
Read Here
Advertise
Sign Up
Events
Event News
He discusses how healthcare systems in Asia Pacific need to evolve beyond simply expanding coverage and towards delivering equitable, sustainable, and high-impact care.
